Table 1.
Baseline patient characteristics.
| Variables | N (%) (total N = 20) | Mean (range) |
|---|---|---|
| Age (years) | 53 (32–67) | |
| Weight (kg) | 60 (38–81) | |
| Height (cm) | 154 (135–167) | |
| BSA (m2) baseline | 1.6 (1.2–1.9) | |
| Cumulative dose of paclitaxel (mg/m2) | 868.0 (160.0–960.0) | |
| Cancer stage | – | |
| Stage 1 | 3 (15) | |
| Stage 2 | 11 (55) | |
| Stage 3 | 5 (25) | |
| Stage 4 | 1 (5) | |
| Type of surgery | – | |
| Breast conservation | 5 (25) | |
| Mastectomy | 15 (75) | |
| Lymph node assessment | – | |
| Sentinel lymph node biopsy | 9 (45) | |
| Axillary clearance | 8 (40) | |
| Both | 3 (15) | |
| ER-positive | 18 (90) | – |
| Her-2-positive | 3 (15) | – |
| Concurrent herceptin | 3 (15) | – |
| TNS baseline | – | |
| 0 | 15 (75) | |
| 1 | 4 (20) | |
| 2 | 1 (5) |